{"name":"Shanghai Haini Pharmaceutical Co., Ltd.","slug":"shanghai-haini-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Norvasc Tablets 5mg","genericName":"Norvasc Tablets 5mg","slug":"norvasc-tablets-5mg","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Norvasc Tablets 5mg","genericName":"Norvasc Tablets 5mg","slug":"norvasc-tablets-5mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQaGN2UXNPTVo0d1JxdkZDYzRxcGxOSUd5VnU0dm9yTHJYNkxtV25MVmdFcmE2UTZfZnJjSXNlVjlDWldJYnp3NTU5WnpuVEw5aDAzMnI5VFkwSGFEM3NWLW1iTE9IcVVrTEM5TEhzTEp3WDNvZTZLUnc3N2k0MHFSdWk3c3dJWlIzRFExNXlBNnozcjBlZlo4SDByRVN0VThpdm9yY3NXaw?oc=5","date":"2025-07-31","type":"deal","source":"India Infoline","summary":"Orchid Pharma buyback rights to novel antibiotic; stock up 5% - India Infoline","headline":"Orchid Pharma buyback rights to novel antibiotic; stock up 5%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPN2pxVmYxZHRKUjd4elVjOUM3UmF5R2x1ek03dXFLNEx6RFBscldycmJRSTNvWkZDQ3UzZjBKYUV4LVR3REpSc3ZKQnR2cktNN2RRSkdMUHJEN0gxSWtoVTUxbnQ2NGYyNUI0Y3g2MVdCVHp4QnZzZzU0aENhUmhQaFhlOUpuS09vNTJDMXo1dEdpNGtKRmV5X0Z2a0JHajlxUzJmSzBZWUc5VkJXMDk3dFhjSG9JcVN10gG-AUFVX3lxTE5QLWxKbjNoOUIwQW4wWnFBenhhOHQxZUhXd3dybllVbF9ER0EzNkdCX3lBTWFSbGF6M1E3ZkF0V25hQWc2R3hGc3k3LVB4eEJDUUY5V0lxenF6MVJ4UTl1THlMd1h5NFlkODJJOW1YUktsM2dCbWdMdS10ZEs3ZEFteDFqS1hOa2hScXM1bS1RbHZDMDhndVNmUTFyRXJyS3dSVzdWSjItNXNPZUZveUhJVDNmU1RpT1R4LVVWTFE?oc=5","date":"2024-03-01","type":"regulatory","source":"medicaldialogues.in","summary":"FDA approves Exblifep for complicated UTI including pyelonephritis - medicaldialogues.in","headline":"FDA approves Exblifep for complicated UTI including pyelonephritis","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxOcTFGVS05ZTRlWWc5LUU3U3RJTXVPQW5yYjNhSG9kMjhhT21qcjlkdnY0ZHlkTkRwWTVzWXFIak1PSFlVS3NPWDFjX0paMXRYYVFUSkNMbWpHdW1JWFljRnlDQWc4RXRmTXpEUlRDTkQtQmRWNm1DN3FXWjYxMEpEN0dSbUV1c2wtTHRfUVFnbHBTeG1Zb3IyR2lVX0k2SVM0RC1jbzIxZE5YQ245YlhUYlV2d3V5ZnRheUFLaWNYay1CZm1UOTVBWU9tai1YY1hudm5yVklDWjAzZ3NjOWEwcFJYSVBCSlNLWmg3cl9nT2p5bVM3RFNHeUhHaGo3Ynd5Rk5TT0N5RQ?oc=5","date":"2024-02-27","type":"regulatory","source":"Business Wire","summary":"Allecra Therapeutics Announces U.S. FDA Approval for EXBLIFEP® for the Treatment of Complicated Urinary Tract Infections - Business Wire","headline":"Allecra Therapeutics Announces U.S. FDA Approval for EXBLIFEP® for the Treatment of Complicated Urinary Tract Infections","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNSzFXczVUMGhmRFdRdzF6ZGRWSmNIbi15VG1pWEZLdEIzamhyb0FUdmpqb05hbVpNZXNTY04xWWJJRks3MWtLSXhXWWlXeG5VOFpMcGJubXFfV251cW5tTW1FQmg3OXNZZlUxNXNQaWR6ZXJSd3RrNFNjZm5qekk3Yk1IVGNLUlV3TG5BUWV5U3poTDRUMWtRcjh4MGpzLWVaa29WejNPUDJKM2U2UXBrczVGTkY?oc=5","date":"2023-02-21","type":"pipeline","source":"BioWorld News","summary":"Carephar’s P-CAB drug gets China nod for duodenal ulcer, reflux esophagitis - BioWorld News","headline":"Carephar’s P-CAB drug gets China nod for duodenal ulcer, reflux esophagitis","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}